阿奇霉素序贯疗法治疗小儿肺炎支原体肺炎临床疗效分析

Analysis of the clinical effect of mycoplasmal pneumonia in children

目的:探讨阿奇霉素与红霉素治疗小儿肺炎支原体肺炎的临床疗效。方法:将124例小儿肺炎支原体肺炎患儿随机分为两组,观察组68,对照组56例,观察组采用阿奇霉素序贯治疗,对照组采用红霉素连续静脉滴注,疗程均为2～3周。对两种治疗方案的临床疗效以及不良反应、住院时间、住院费用进行对比分析。结果:观察组痊愈42例,好转26例,总有效率100%,对照组,痊愈38例,好转18例,总有效率为100%,两组比较差异无显著性(P>0.05),但观察组的不良反应、住院时间、住院费用均明显低于对照组。结论:阿奇霉素序贯治疗小儿肺炎支原体肺炎有效、安全、经济。

Objective ：To evaluate the cost-effectiveness of azithromycin and erythromyein in the treatment of myeoplasmal pneumonia in children.Methods： 124 mycoplasmal pneumonia patients were divided into two groups;the observation group（68 eases） and control group （56 eases）.The observation group received azithromyein by sequential therapy.The control group received erythromyein by intravenous administration.AU the patients were treated for 2 or 3 week.A comparison was made between two groups in the way of pharmaeoeeonomies cost-effectiveness analysis. Results：The reeovery rates of two groups were all 100%. But the side effects, hospitalizing days and the average eost of the sequential therapy group were less than those of the group of erythromyein intravenous administration.Conclusion ：Azithromycin sequential therapy in the treatment of mycoplasmal pneumonia can ensure curative effect,safety and economy.